Top Markets
Coin of the day
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Rang in Aktien #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Aktienkurs
$0.2488447
Zuletzt synchronisiert: 2024-10-01
Marktkapitalisierung
$2.01M
Veränderung (1 Tag)
-1.88%
Veränderung (1 Jahr)
0.00%
Land
IN
Handel Ortin Laboratories Limited (ORTINLAB)

Kategorie

EPS für Ortin Laboratories Limited (ORTINLAB)
EPS zum June 2024 TTM: $-0.12
Laut den aktuellen Finanzberichten und dem Aktienkurs von Ortin Laboratories Limited beträgt das aktuelle EPS des Unternehmens (TTM) $-0.12. Am Ende des Jahres 2023 betrug das EPS $0.00 eine Steigerung gegenüber dem EPS von 2022, das $-0.01 betrug.
EPS-Verlauf von Ortin Laboratories Limited von 2008 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-0.12 0.33%
2024 $-0.12 11,760.00%
2023 0.00 -84.62%
2022 $-0.01 -141.14%
2021 $0.02 -271.74%
2020 $-0.01 -140.71%
2019 $0.02 75.19%
2018 $0.01 32.99%
2017 $0.01 -37.01%
2016 $0.02 -12.50%
2015 $0.02 -27.87%
2014 $0.02 -0.41%
2013 $0.02 -20.45%
2012 $0.03 -57.75%
2011 $0.07 -29.90%
2010 $0.10 49.21%
2009 $0.07 -46.67%
2008 $0.13 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber